IMPAKT: Improving Indigenous Patients' Access To Kidney Transplantation.
Funder
National Health and Medical Research Council
Funding Amount
$444,725.00
Summary
Indigenous Australians develop end-stage renal disease (ESRD) at up to thirty times the rate for non-Indigenous Australians. Almost a half of Indigenous ESRD patients come from remote regions without ESRD treatment services. People with end-stage renal disease (ESRD) need dialysis or a transplant to stay alive. Most patients from remote communities need to relocate to regional centres to receive haemodialysis. This causes profound isolation, significant community disruption and worsens survival. ....Indigenous Australians develop end-stage renal disease (ESRD) at up to thirty times the rate for non-Indigenous Australians. Almost a half of Indigenous ESRD patients come from remote regions without ESRD treatment services. People with end-stage renal disease (ESRD) need dialysis or a transplant to stay alive. Most patients from remote communities need to relocate to regional centres to receive haemodialysis. This causes profound isolation, significant community disruption and worsens survival. Transplantation is the best treatment for most people with ESRD. Compared with long-term dialysis, it is associated with a better quality of life, a longer life expectancy, and lower costs to the health-care system. Indigenous Australians are over-represented in the ESRD population, but have a significantly lower chance of receiving a transplant than non-indigenous Australians. In this research, the IMPAKT study, we aim to identify Indigenous Australians' barriers to access to renal transplantation for treatment of their ESRD, and to propose strategies to reduce disparities in Indigenous Australians' access to renal transplantation. The nephrologists who regulate access to renal transplantation in Australia are members of the research team. This should facilitate the translation of research findings into improved access to renal transplantation for Indigenous patients.Read moreRead less
Antecedents Of Renal Disease In Aboriginal Children And Young Adults - 12 Year Follow-up
Funder
National Health and Medical Research Council
Funding Amount
$1,845,061.00
Summary
Aboriginal Australians have 2 to 10 times the rate of chronic kidney disease and premature death from cardiovascular disease compared with non-Aboriginal Australians. Our 6 year follow-up of Aboriginal children from diverse NSW areas has shown no increase in risk for these diseases when compared with non-Aboriginal children. The ARDAC Second Phase Study will follow the participants for another 6 years to determine whether these health disparities start to manifest in young Aboriginal adults.